ITIH1 and cancer: Our in-silico analyses using the TCGA pan-cancer datasets showed that, despite that ITIH1-ITIH4 were significantly altered in several cancer types, their basal expression levels in most cancers and corresponding normal tissues were extremely low, except for CHOL and LIHC.